Inventor · disambiguated record
Isaac Marx
Also filed as: MARX ISAAC · MARX ISAAC E
21 granted patents·12 pending applications·117 citations·filing 2008–2025
94Inventor score
Top patents by PatentIndex Score
33 records- 0194US8426447B2Spiro-tricyclic ring compounds as beta-secretase modulators and methods of useWHITE RYAN·Filed 2009·Granted Apr 23, 2013·58 cites·22 claims
- 0293US11427577B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2021·Granted Aug 30, 2022·2 cites·9 claims
- 0392US10961237B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2019·Granted Mar 30, 2021·4 cites·6 claims
- 0490US10227341B2Inhibiting agents for bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Mar 12, 2019·8 cites·26 claims
- 0589US10189829B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·6 cites·8 claims
- 0687US7776857B2Aurora kinase modulators and method of useAMGEN INC·Filed 2008·Granted Aug 17, 2010·10 cites·17 claims
- 0783US11807634B2Cyclopropyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2021·Granted Nov 7, 2023·1 cites·27 claims
- 0882US11858926B2Inhibiting agents for bruton's tyrosine kinaseBIOGEN MA INC·Filed 2022·Granted Jan 2, 2024·0 cites·5 claims
- 0981US9776995B2Bicyclic sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2014·Granted Oct 3, 2017·4 cites·24 claims
- 1080US12391697B2Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Aug 19, 2025·1 cites·20 claims
- 1180US9012443B2Bicyclic aryl and heteroaryl sodium channel inhibitorsAMGEN INC·Filed 2012·Granted Apr 21, 2015·6 cites·32 claims
- 1280US9012446B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2013·Granted Apr 21, 2015·4 cites·20 claims
- 1377US9212182B2Bicyclic sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2014·Granted Dec 15, 2015·3 cites·32 claims
- 1476US9458152B2Bicyclic sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2015·Granted Oct 4, 2016·2 cites·18 claims
- 1576US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 1673US10899753B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2019·Granted Jan 26, 2021·1 cites·20 claims
- 1769US8557816B2Aurora kinase modulators and method of useGEUNS-MEYER STEPHANIE·Filed 2011·Granted Oct 15, 2013·2 cites·9 claims
- 1868US12240839B2Cyclobutyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2021·Granted Mar 4, 2025·0 cites·14 claims
- 1967US2023135894A1Mk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2065US2025171425A1Uses of cyclobutyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2025·Application pending·0 cites
- 2164US9079902B2Heteroaryl sodium channel inhibitorsDINEEN THOMAS·Filed 2012·Granted Jul 14, 2015·1 cites·19 claims
- 2264US2021387978A1Cyclobutyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2021·Application pending·0 cites
- 2360US2025179075A1Mk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2460US2025051338A1Tyk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2559US2020009129A1Alkyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2019·Application pending·0 cites
- 2657US2025034150A1Btk inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 2756US2024287076A1Compounds for targeting degradation of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 2852US2024083900A1Pyrazolo[1,5-a]pyrazine derivatives as btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 2952US2024327380A1Btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 3049US12240838B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Mar 4, 2025·0 cites·21 claims
- 3146US2011301162A1Aurora kinase modulators and methods of useDEAK HOLLY L·Filed 2009·Application pending·0 cites
- 3244US2014336182A1Aurora Kinase Modulators and Method of UseAMGEN INC·Filed 2013·Application pending·0 cites
- 3342US9346798B2Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitorsAMGEN INC·Filed 2013·Granted May 24, 2016·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Isaac Marx files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →